Edelman's Perceptive Advisors Buying Amicus Therapeutics Ahead Of Phase III Data Release

Edelman’s Perceptive Advisors Buying Amicus Therapeutics Ahead Of Phase III Data Release

Video Chart Review And Market Commentary July 15 2014 – Small Cap Pressure And Reasons Why

AcelRx Should Trend Higher As FDA Approval Is Likely At End Of This Month

AcelRx Should Trend Higher As FDA Approval Is Likely At End Of This Month

Activist Investor David Callan Has Been Accumulating Identiv Stock, Here is Why

Activist Investor David Callan Has Been Accumulating Identiv Stock, Here is Why

Updated With Options Activity Reflected: Acquisition Thesis on Volcano Corp.

Updated With Options Activity Reflected: Acquisition Thesis on Volcano Corp.

Research Report And Thesis On Halozyme

Research Report And Thesis On Halozyme

← →
  • Edelman's Perceptive Advisors Buying Amicus Therapeutics Ahead Of Phase III Data Release
  • AcelRx Should Trend Higher As FDA Approval Is Likely At End Of This Month
  • Activist Investor David Callan Has Been Accumulating Identiv Stock, Here is Why
  • Updated With Options Activity Reflected: Acquisition Thesis on Volcano Corp.
  • Research Report And Thesis On Halozyme
Browse: Home

Recent Articles

Wednesday Morning Market Commentary July 23 - Tech

Wednesday Morning Market Commentary July 23 – Tech

by
, , ,

Wednesday Morning Market Commentary July 23 – Potential Tech Rally on Tap. $AAPL Bottom line earnings beat, Top Line misses on Ipad weakness seen as…

Read Article →
Video Market Commentary For Monday July 21 - Phony Market Selling Including INVE

Video Market Commentary For Monday July 21 – Phony Market Selling Including INVE

by
, , ,

Video Market Commentary For Monday July 21 – Phony Market Selling Including INVE. As I stated on the premium twitter account, I strongly felt the…

Read Article →
Video Market Wrap Commentary For Friday July 18 - Market Goes as Expected

Video Market Wrap Commentary For Friday July 18 – Market Goes as Expected

by
, , ,

Video Market Wrap Commentary  For  Friday  July  18 – Market  Goes as Expected. With the exception of the markets opening higher today, they went as…

Read Article →

More Articles

Updated And Amended: Why Mannkind’s Afrezza Is No Blockbuster And Will Be Rejected By FDA

/ by / in , ,

Updated:Trade Alert: $OPXA – Target – $2.65

/ by / in

Video: Mid-Week Commentary And Update 11/13/13

/ by / in ,

Trade Alert: $EBIX – Stopped out, Bad trade call

/ by / in

Updated Videos With Charts : Market Commentary, What I’m looking at, and What to Expect For Tuesday 11/6/13 (Premium Content)

/ by / in , ,

Solta Board Member’s Home addresses and Instructions what to write

/ by / in

Video: Stock Updates and Commentary For 10/30/13

/ by / in ,

Market Update and Commentary for 10/23/13 (Premium Content)

/ by / in ,

$SSH Analyst Opinion Excerpts (Premium Content)

/ by / in ,

Video: Charts and Commentary For 10/20/13 (Premium Content)

/ by / in ,

Near-Term Catalyst Could Double Enanta’s Market Cap

/ by / in ,

Video: Market Commentary for 10/15/13 (Premium Content)

/ by / in ,
s2Member®